Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum
J. Sautter et al., Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum, EXP NEUROL, 164(1), 2000, pp. 121-129
Cryopreservation may allow long-term storage of embryonic ventral mesenceph
alon (VM) for neural transplantation. We investigated whether the gangliosi
de GM1 or the lazaroid tirilazad mesylate (U-74006F) could improve survival
of grafts derived from cryopreserved VM in a rat model of Parkinson's dise
ase. VM was dissected from rat embryos (E14-E15), frozen and stored in liqu
id nitrogen under controlled conditions, thawed, dissociated, and then graf
ted into the 6-hydroxydopamine-lesioned rat striatum. In Experiment I, VM f
ragments were exposed in vitro either to GM1 (100 mu M) or to lazaroid (0.3
mu M) during all preparative steps. In Experiment II, rats receiving GM1-p
retreated VM were, in addition, treated systematically with GM1 (30 mg/kg)
daily for 3.5 weeks. Rats grafted with untreated cryopreserved or fresh VM
were used as controls, respectively. Rats receiving fresh VM control grafts
showed complete recovery from lesion-induced rotations after 6 weeks where
as rats grafted with cryopreserved VM (untreated or pretreated) did not rec
over. Cryografts contained significantly less (18%, control; 23%, GM1; and
12%, lazaroid) tyrosine hydroxylase-positive cells compared to fresh grafts
(1415 +/- 153; mean +/- SEM). Graft volume was also significantly smaller
after cryopreservation. In contrast, with additional systemic GM1 treatment
cryografts contained almost the same number of tyrosine hydroxylase-positi
ve cells (376 +/- 85) as fresh grafts (404 +/- 56), which was significantly
more than that of untreated cryografts (147 +/- 20), showed a significantl
y larger volume (0.15 mm(3)) compared to that of untreated grafts (0.08 mm(
3)) (fresh controls, 0.19 mm(3)), and induced significant and complete func
tional recovery in the rotation. test. In conclusion, systemic treatment of
rats with GM1 improved the low survival and functional inefficacy of graft
s derived from cryopreserved VM. whereas tissue pretreatment alone with eit
her GM1 or lazaroid was not effective, (C) 2000 Academic Press.